AQR Arbitrage’s Translational Development Acquisition Corp TDAC Stock Holding History

AQR Arbitrage’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4M	Sell	974,300 -119,910	-11%	-$1.28M	0.15%	136
2026 Q1	$11.6M	Sell	1,094,210 -2,779	-0.3%	-$29.3K	0.19%	116
2025 Q4	$11.5M	Hold	1,096,989	–	–	0.24%	107
2025 Q3	$11.3M	Sell	1,096,989 -3,000	-0.3%	-$31K	0.29%	117
2025 Q2	$11.3M	Hold	1,099,989	–	–	0.26%	117
2025 Q1	$11.1M	Buy	+1,099,989	New	+$11M	0.26%	120

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

AQR Arbitrage's TDAC Position: Q2 2026 in Review

AQR Arbitrage reduced its Translational Development Acquisition Corp (TDAC) stake by 11% in Q2 2026, selling an estimated $1.28M and leaving 974,300 shares worth $10.4M. The position accounts for 0.15% of the portfolio, ranked #136.

AQR Arbitrage first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.6M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

AQR Arbitrage held 974,300 shares of Translational Development Acquisition Corp worth $10.4M as of Q2 2026.
AQR Arbitrage sold 119,910 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.28M.
Translational Development Acquisition Corp made up 0.15% of AQR Arbitrage's portfolio in Q2 2026, its #136 holding.
AQR Arbitrage first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
AQR Arbitrage's Translational Development Acquisition Corp position peaked at $11.6M in Q1 2026.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.